Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Rheumatology|April 22, 2015
The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritisMartin Feuchtenberger, Stefan Kleinert, Eva-Christina Scharbatke, et al.
The Open Rheumatology Journal|June 7, 2012
Renal perfusion in scleroderma patients assessed by microbubble-based contrast-enhanced ultrasoundStefan Kleinert, Petra Roll, Christian Baumgaertner, et al.
Rheumatology International|August 5, 2025
Discordance between patient and physician reported global disease activity in PsA is associated with mental health-a cross-sectional analysisAnne C Regierer, Kirsten Karberg, Cay-Benedict von der Decken, et al.
Rheumatology International|February 18, 2011
Vaccination survey in patients with rheumatoid arthritis: a cross-sectional studyMartin Feuchtenberger, Stefan Kleinert, Sven Schwab, et al.
Arthritis Care & Research|April 24, 2013
Development and validation of a new disease activity score in 28 joints-based treatment response criterion for rheumatoid arthritisFrank Behrens, Hans-Peter Tony, Rieke Alten, et al.
Rheumatology International|August 9, 2011
Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational studyStefan Kleinert, Hans-Peter Tony, Andreas Krause, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2018
Prevalence and Characteristics of Persistent Clonal T Cell Large Granular Lymphocyte Expansions in Rheumatoid Arthritis: A Comprehensive Analysis of 529 PatientsEva C Schwaneck, Regina Renner, Lara Junker, et al.
Rheumatology and Therapy|January 21, 2025
Real-World-Evidence of Digital Health Applications (DiGAs) in Rheumatology: Insights from the DiGAReal RegistryAlexander Albrecht, Jule Taubmann, Ioanna Minopoulou, et al.
Frontiers in Medicine|November 18, 2021
Prevalence of Depressive Symptoms in Patients With Psoriatic Arthritis: Have Numbers Changed During the COVID-19 Pandemic?Matthias Englbrecht, Peter Bartz-Bazzanella, Cay von der Decken, et al.
Rheumatology International|April 28, 2025
RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settingsCay-Benedict von der Decken, Stefan Kleinert, Matthias Englbrecht, et al.
Pageof 5